Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs
Publication year
2018Source
Clinical Infectious Diseases, 67, 11, (2018), pp. 1743-1749ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Medical Microbiology
Journal title
Clinical Infectious Diseases
Volume
vol. 67
Issue
iss. 11
Page start
p. 1743
Page end
p. 1749
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [227207]
- Faculty of Medical Sciences [86711]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.